156 related articles for article (PubMed ID: 23083114)
1. Effects of meloxicam and phenylbutazone on equine gastric mucosal permeability.
D'Arcy-Moskwa E; Noble GK; Weston LA; Boston R; Raidal SL
J Vet Intern Med; 2012; 26(6):1494-9. PubMed ID: 23083114
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and safety of single and multiple oral doses of meloxicam in adult horses.
Noble G; Edwards S; Lievaart J; Pippia J; Boston R; Raidal SL
J Vet Intern Med; 2012; 26(5):1192-201. PubMed ID: 22860573
[TBL] [Abstract][Full Text] [Related]
3. Lower gastric ulcerogenic effect of suxibuzone compared to phenylbutazone when administered orally to horses.
Monreal L; Sabaté D; Segura D; Mayós I; Homedes J
Res Vet Sci; 2004 Apr; 76(2):145-9. PubMed ID: 14672858
[TBL] [Abstract][Full Text] [Related]
4. Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS).
Ricord M; Andrews FM; Yñiguez FJM; Keowen M; Garza F; Paul L; Chapman A; Banse HE
Equine Vet J; 2021 Mar; 53(2):356-363. PubMed ID: 32697849
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of oral meloxicam and phenylbutazone in 2 experimental pain models in the horse.
; Banse H; Cribb AE
Can Vet J; 2017 Feb; 58(2):157-167. PubMed ID: 28216685
[TBL] [Abstract][Full Text] [Related]
6. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses.
Reed SK; Messer NT; Tessman RK; Keegan KG
Am J Vet Res; 2006 Mar; 67(3):398-402. PubMed ID: 16506899
[TBL] [Abstract][Full Text] [Related]
7. Orally administered phenylbutazone causes oxidative stress in the equine gastric mucosa.
Martínez Aranzales JR; Cândido de Andrade BS; Silveira Alves GE
J Vet Pharmacol Ther; 2015 Jun; 38(3):257-64. PubMed ID: 25287371
[TBL] [Abstract][Full Text] [Related]
8. Phenylbutazone induces equine glandular gastric disease without decreasing prostaglandin E
Pedersen SK; Cribb AE; Read EK; French D; Banse HE
J Vet Pharmacol Ther; 2018 Apr; 41(2):239-245. PubMed ID: 29148168
[TBL] [Abstract][Full Text] [Related]
9. Clinical effects of a combination of phenylbutazone and omeprazole on chronic lameness in Mongolian horses.
Li Z; Du S; Wang X; Zhang L; Liu X; Fan Q; Yang H; Gao R
Equine Vet J; 2024 May; 56(3):562-572. PubMed ID: 37337455
[TBL] [Abstract][Full Text] [Related]
10. Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs.
Smecuol E; Bai JC; Sugai E; Vazquez H; Niveloni S; Pedreira S; Mauriño E; Meddings J
Gut; 2001 Nov; 49(5):650-5. PubMed ID: 11600467
[TBL] [Abstract][Full Text] [Related]
11. The protective effects of sucralfate and ranitidine in foals experimentally intoxicated with phenylbutazone.
Geor RJ; Petrie L; Papich MG; Rousseaux C
Can J Vet Res; 1989 Apr; 53(2):231-8. PubMed ID: 2713788
[TBL] [Abstract][Full Text] [Related]
12. Serum protein expression in Equine Glandular Gastric Disease (EGGD) induced by phenylbutazone.
Tesena P; Yingchutrakul Y; Roytrakul S; Wongtawan T; Angkanaporn K
J Vet Med Sci; 2019 Mar; 81(3):418-424. PubMed ID: 30674748
[TBL] [Abstract][Full Text] [Related]
13. Mucosal damage induced by preferential COX-1 and COX-2 inhibitors: role of prostaglandins and inflammatory response.
Villegas I; La Casa C; de la Lastra CA; Motilva V; Herrerías JM; Martín MJ
Life Sci; 2004 Jan; 74(7):873-84. PubMed ID: 14659976
[TBL] [Abstract][Full Text] [Related]
14. Effects of meloxicam and phenylbutazone on renal responses to furosemide, dobutamine, and exercise in horses.
Raidal SL; Hughes KJ; Charman AL; Nielsen SG; Phillips JK; Noble GK
Am J Vet Res; 2014 Jul; 75(7):668-79. PubMed ID: 24959734
[TBL] [Abstract][Full Text] [Related]
15. Effects of top-dress formulations of suxibuzone and phenylbutazone on development of gastric ulcers in horses.
Andrews FM; Reinemeyer CR; Longhofer SL
Vet Ther; 2009; 10(3):113-20. PubMed ID: 20037965
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic effects of Glycyrrhiza glabra root extract on phenylbutazone-induced Equine Glandular Gastric Disease (EGGD).
Ahmadnejad M; Jalilzadeh-Amin G; Sykes BW
J Equine Vet Sci; 2022 Nov; 118():104088. PubMed ID: 35908599
[TBL] [Abstract][Full Text] [Related]
17. In vivo effects of phenylbutazone on inflammation and cartilage-derived biomarkers in equine joints with acute synovitis.
de Grauw JC; van Loon JP; van de Lest CH; Brunott A; van Weeren PR
Vet J; 2014 Jul; 201(1):51-6. PubMed ID: 24888681
[TBL] [Abstract][Full Text] [Related]
18. Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses.
MacAllister CG; Morgan SJ; Borne AT; Pollet RA
J Am Vet Med Assoc; 1993 Jan; 202(1):71-7. PubMed ID: 8420909
[TBL] [Abstract][Full Text] [Related]
19. Comparison of flunixin meglumine and meloxicam for post operative management of horses with strangulating small intestinal lesions.
Naylor RJ; Taylor AH; Knowles EJ; Wilford S; Linnenkohl W; Mair TS; Johns IC
Equine Vet J; 2014 Jul; 46(4):427-34. PubMed ID: 24372991
[TBL] [Abstract][Full Text] [Related]
20. COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.
Beretta C; Garavaglia G; Cavalli M
Pharmacol Res; 2005 Oct; 52(4):302-6. PubMed ID: 15939622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]